Pilot Award Recipient: Georges Haddad, PhD
The pandemic of the Acquired Immunodeficiency Syndrome due to the lentiviral retrovirus, Human Immunodeficiency Virus Type 1 (HIV-1) is still affecting millions of people.
Pilot Awards Recipients
The DC CFAR has funded a wide variety of research, including basic, clinical, epidemiologic, social behavioral and prevention HIV/AIDS science.
View the archive to learn more about awards given in 2017 or earlier.
Pilot Award Recipient: Yan Wang, DrPH, MD
Globally, female sex workers (FSW) are disproportionately affected by HIV compared to adult women overall.
Pilot Award Recipient: Alexander Zestos, PhD
While a number of drugs are used intravenously in people living with HIV, one group of drugs receiving increasing attention are the opiates as opiate users nearly tripled from 2009-2016.
Pilot Award Recipient: Mark Laubach, PhD
This project will investigate how toxins produced by HIV1 and antiretroviral therapies used to treat HIV impact the frontal cortex.
Pilot Award Recipient: Ruth Kanthula, MD, MPH
Antiretroviral therapy (ART) allows HIV to be managed as a chronic condition.
Pilot Award Recipient: Katherine Chiappinelli, PhD
The presence of a reservoir of latently infected cells has become the major hurdle for HIV eradication and its elimination is a scientific priority to cure HIV.
Pilot Award Recipient: Chul Kim, MD, MPH
People living with HIV (PLWH) are at risk for developing diverse malignancies.
Pilot Award Recipient: Thomas Heinbockel, PhD
Since marijuana is widely used and gains more social acceptability in the U.S., it is critical to understand if, and how, marijuana and cannabinoids impact HIV.
Pilot Award Recipient: Ana María del Río-González, PhD, MA
Along with other transgender women (i.e., those assigned a male sex at birth, but who identify as female) of color, Latina transgender women (LTW) in Washington DC are heavily impacted by HIV.
Pilot Award Recipient: Conrad Russell Cruz, MD, PhD
Although HIV infection can be controlled by daily lifelong adherence to expensive antiretroviral therapies it cannot presently be cured.